PMID: 9646781Jul 1, 1998Paper

Unfractionated and low-molecular-weight heparin. Comparisons and current recommendations

The Medical Clinics of North America
G F Pineo, R D Hull

Abstract

Intravenous heparin followed by warfarin has been the classical anticoagulant therapy of acute venous thromboembolism for the past 30 years. In recent years a number of low-molecular-weight heparins have become available for clinical trials. These agents have a number of advantages over unfractionated heparin and are now being used internationally for the prevention and treatment of venous thromboembolism. Low-molecular-weight heparin will undoubtedly replace intravenous unfractionated heparin not only in the treatment of venous thromboembolism but in other conditions where heparin therapy is indicated. Whether or not the low-molecular-weight heparins can decrease or eliminate some of the complications of unfractionated heparin will depend on the outcome of future clinical trials.

References

Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·U LindahlA Linker
Mar 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R D Rosenberg, L Lam
Nov 19, 1992·The New England Journal of Medicine·D P BrandjesJ W ten Cate
Jul 16, 1992·The New England Journal of Medicine·P ThérouxJ McCans
Jan 5, 1985·British Medical Journal·A G FennertyP A Routledge
Jan 1, 1980·The Journal of Clinical Investigation·E W SalzmanL Favreau
Jan 1, 1982·Clinical Pharmacology and Therapeutics·T D BjornssonB B Kitchell
Oct 1, 1995·Chest·J S Ginsberg, J Hirsh
Jan 1, 1994·British Journal of Obstetrics and Gynaecology·F SturridgeE Letsky
Jun 1, 1993·British Journal of Haematology·L K BoshkovJ G Kelton
Jul 15, 1993·Annals of Internal Medicine·P Brill-EdwardsJ Hirsh
Dec 1, 1995·American Journal of Clinical Pathology·J G Kelton, T E Warkentin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.